Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $136.4400 (-0.81%) ($135.2200 - $136.8350) on Tue. May. 30, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.44% (three month average) | RSI | 17 | Latest Price | $136.4400(-0.81%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -1.2% a day on average for past five trading days. | Weekly Trend | ABBV declines -2.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) IBB(16%) XBI(14%) XLU(13%) XOP(13%) IDRV(10%) | Factors Impacting ABBV price | ABBV will decline at least -0.72% in a week (0% probabilities). BWX(-15%) IPO(-12%) BNDX(-12%) XLC(-11%) SMH(-9%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.72% (StdDev 1.44%) | Hourly BBV | -1.1 () | Intraday Trend | 0.7% | | | |
|
Resistance Level | $144.46 | 5 Day Moving Average | $139.26(-2.02%) | 10 Day Moving Average | $141.48(-3.56%) | 20 Day Moving Average | $144.46(-5.55%) | To recent high | -17.3% | To recent low | 0% | Market Cap | $240.719b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |